Supplementary file

Published: 2 April 2025| Version 1 | DOI: 10.17632/vcr7ctgbhf.1
Contributor:
Jinhua Xu

Description

Supplementary fle to: Ivarmacitinib Ointment for the Treatment of Adults with Mild-to-Moderate Atopic Dermatitis: Phase 3 part of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Clinical Trial

Files

Categories

Clinical Trial

Funders

  • Jiangsu Hengrui Pharmaceuticals

Licence